FDA Approves Crisaborole (Eucrisa) for Atopic Dermatitis – Medscape
Medscape |
FDA Approves Crisaborole (Eucrisa) for Atopic Dermatitis
Medscape The US Food and Drug Administration (FDA) has approved crisaborole (Eucrisa, Anacor Pharmaceuticals, Inc) for the treatment of mild to moderate atopic dermatitis (eczema) in patients aged 2 years and older. “Today’s approval provides another treatment … FDA approves Pfizer ointment for chronic itchy skin condition FDA approves Eucrisa for eczema FDA Approves Pfizer’s Eucrisa For Eczema |
View original article
Author:
Powered by WPeMatico
Health Topic Contributor
Editors and curators bringing you the latest and most impactful health news. Truly objective, we print links to stories and studies that may contradict one another. If you're searching for news on health studies, alternative health modalities, facts on modern allopathic medicine, and more, we're you're team bringing you the stories and facts that matter.